Send us Feedback

Abraxis BioScience (ABII)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ABII » Topics » Relationships Among Directors or Executive Officers

This excerpt taken from the ABII DEF 14A filed Oct 30, 2009.

Relationships Among Directors or Executive Officers

There are no family relationships among any of our directors or executive officers.

These excerpts taken from the ABII 10-K filed Apr 30, 2009.

Relationships Among Directors or Executive Officers

There are no family relationships among any of our directors or executive officers.

Relationships Among
Directors or Executive Officers

There are no family relationships among any of our directors or executive officers.

STYLE="margin-top:18px;margin-bottom:0px">Section 16(a) Beneficial Ownership Reporting Compliance

SIZE="2">Section 16(a) of the Exchange Act requires our directors, executive officers and persons who own more than 10% of our common stock (collectively, “Reporting Persons”) to file reports of ownership and changes in ownership of
our common stock. Reporting Persons are required by Securities and Exchange Commission regulations to furnish us with copies of all Section 16(a) reports they file. Based solely on our review of the copies of such reports received or written
representations from the Reporting Persons, we believe that during the fiscal year ended December 31, 2008, all Reporting Persons complied with these filing requirements on a timely basis.

STYLE="margin-top:18px;margin-bottom:0px">Code of Ethics

We have adopted a code of ethics
entitled “Abraxis BioScience, Inc. Code of Business Conduct” which applies to all of our employees, officers and directors, including our principal executive officer, principal financial officer, principal accounting officer and all
persons performing similar functions. In addition, all employees at a vice president level or above certify compliance with the Code of Business Conduct on an annual basis. Our Code of Business Conduct was filed as an exhibit to our Annual Report on
Form 10-K for the year ended December 31, 2007. Our Code of Business Conduct may also be viewed at our website at http://www.abraxisbio.com. The information contained on our website is not intended to be, nor shall it be incorporated by
reference into, this filing.

The Audit Committee has reviewed and approved policies and procedures for (a) the receipt, retention and
treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters, and (b) the confidential and anonymous submission by our employees, of concerns regarding questionable accounting or auditing
matters. These procedures are described in our Code of Business Conduct under the heading “Reporting Procedures and Other Inquiries.”

 


6







This excerpt taken from the ABII DEF 14A filed Oct 3, 2008.

Relationships Among Directors or Executive Officers

There are no family relationships among any of our directors or executive officers.

These excerpts taken from the ABII 10-K filed May 5, 2008.

Relationships Among Directors or Executive Officers

There are no family relationships among any of our directors or executive officers.

Relationships Among Directors or
Executive Officers

There are no family relationships among any of our directors or executive officers.

STYLE="margin-top:18px;margin-bottom:0px">Section 16(a) Beneficial Ownership Reporting Compliance

SIZE="2">Section 16(a) of the Exchange Act requires our directors, executive officers and persons who own more than 10% of our common stock (collectively, “Reporting Persons”) to file reports of ownership and changes in ownership of
our common stock. Reporting Persons are required by Securities and Exchange Commission regulations to furnish us with copies of all Section 16(a) reports they file. Based solely on our review of the copies of such reports received or written
representations from the Reporting Persons, we believe that during the fiscal year ended December 31, 2007, all Reporting Persons complied with these filing requirements on a timely basis.

STYLE="margin-top:18px;margin-bottom:0px">Code of Ethics

We have adopted a code of ethics
entitled “Abraxis BioScience, Inc. Code of Business Conduct” which applies to all of our employees, officers and directors, including our principal executive officer, principal financial officer, principal accounting officer and all
persons performing similar functions. In addition, all employees, at a vice president level or above, certify compliance with the Code of Business Conduct on an annual basis. Our Code of Business Conduct was filed as an exhibit to our Annual Report
on Form 10-K for the year ended December 31, 2007. Our Code of Business Conduct may also be viewed at our website at http://www.abraxisbio.com. The information contained on our website is not intended to be, nor shall it be incorporated
by reference into, this filing.

The Audit Committee has reviewed and approved policies and procedures for (a) the receipt, retention
and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters, and (b) the confidential and anonymous submission by our employees, of concerns regarding questionable accounting or auditing
matters. These procedures are described in our Code of Business Conduct under the heading “Reporting Procedures and Other Inquiries.”

 


9







This excerpt taken from the ABII 8-K filed Nov 8, 2007.

Relationships Among Directors or Executive Officers

There are no family relationships among any of our directors or executive officers.

EXCERPTS ON THIS PAGE:

DEF 14A
Oct 30, 2009
10-K (2 sections)
Apr 30, 2009
DEF 14A
Oct 3, 2008
10-K (2 sections)
May 5, 2008
8-K
Nov 8, 2007

RELATED TOPICS for ABII:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki